Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry

Annals of Surgical Oncology

Volumn 15, Issue 3, 2008, Pages 934-940

  Beavis, Alison ^a   Dawson, Michael ^a   Doble, Philip ^a   Scolyer, Richard A ^b,c   Bourne, Roger ^e   Li, Ling Xi L ^b   Murali, Rajmohan ^b,c   Stretch, Jonathan R ^b,d   Lean, Cynthia L ^f   Uren, Roger F ^b,c   Thompson, John F ^b,d  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Sydney   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f CANCER INSTITUTE NSW   (Australia)

Author keywords

Clinical; Fine needle biopsy; Melanoma; Pathology; Sentinel lymph node

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DYE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHOSCINTIGRAPHY; MASS SPECTROMETRY; NEEDLE BIOPSY; PREOPERATIVE PERIOD; SENTINEL LYMPH NODE BIOPSY; STATISTICAL SIGNIFICANCE; TISSUE LEVEL;

ANTIMONY; BIOPSY, FINE-NEEDLE; HUMANS; LYMPH NODES; MASS SPECTROMETRY; MELANOMA; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 39149140698     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9693-0     Document Type: Article

References (30)

1. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9
2. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67
3. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60
4. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17
5. Cecchi R, De Gaudio C, Buralli L, Innocenti S. Lymphatic mapping and sentinel lymph node biopsy in the management of primary cutaneous melanoma: report of a single-centre experience. Tumori 2006;92:113-7
6. Clary BM, Mann B, Brady MS, Lewis JJ, Coit DG. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 2001;8:328-37
7. Corrigan MA, Coffey JC, O'Sullivan MJ, Fogarty KM, Redmond HP. Sentinel lymph node biopsy: is it possible to reduce false negative rates by excluding patients with nodular melanoma? Surg J R Coll Surg E 2006;4:153-7
8. Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BBR. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-8
9. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999;134:381-7
10. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003;27:1197-202
11. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-11
12. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-one institution's experience. Melanoma Res 2002;13:35-43
13. Rossi CR, De Salvo GL, Trifiro G, et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med 2006;47:234-41
14. Statius Muller MG, Borgstein PJ, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow up. Ann Surg Oncol 2000;7:461-8
15. van Akkooi AC, de Wilt JH, Verhoef C, et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006;42:372-80
16. Yee VSK, Thompson JF, McKinnon JG, Scolyer RA, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 2005;12:429-39
17. Dawson M, Doble P, Beavis A, Li LX, et al. Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst 2003;128:217-9
18. Scolyer RA, Thompson JF, Li LX, et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients. Ann Surg Oncol 2004;11(3 Suppl):174S-8S
19. Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003;10:676-80
20. Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. Eur J Surg Oncol 2004;30:851-6
21. Agnese DM, Abdessalam SF, Burak J, et al. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003;134:542-7
22. Stretch JR, Somorjai R, Bourne R, et al. Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Ann Surg Oncol 2005;12:943-9
23. Lean CL, Bourne R, Thompson JF, et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy samples. Melanoma Res 2003;13:259-61
24. Uren RF, Thompson JF, Howman-Giles R, Chung DKV. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surg Oncol Clin North Am 2006;15:285-300
25. Balch CM, Cascinelli N. Sentinel-node biopsy in melanoma. N Engl J Med 2006;355:1370-1
26. Scolyer RA, Thompson JF, Li LX, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004;17:1191-7
27. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer 2001;92:535-41
28. Lucci A, Turner RR, Morton DL. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery 1999;126:48-53
29. Mangas C, Hilari JM, Paradelo C, Rex J, et al. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase- polymerase chain reaction for tyrosinase in melanoma patients. Ann Surg Oncol 2006;13:910-8
30. Tatlidil C, Parkhill WS, Giacomantonio CA, Greer WL, Morris SF, Walsh NM. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence. Mod Pathol 2007;20:427-34